-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

PF4 Antibodies in Monoclonal Gammopathy of Thrombotic Significance

Scientific Workshop on the Interplay between Coagulation and Malignancy
Program: Scientific Workshops
Session: Coagulation Alterations in Hematologic Malignancies
Friday, December 8, 2023, 2:05 PM-3:00 PM

Anand Pabmanabhan, MBBS, PhD

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Disclosures: Pabmanabhan: Mayo Clinic: Current Employment, Patents & Royalties; Versiti Inc: Patents & Royalties; Veralox Therapeutics: Current equity holder in private company; Retham Technologies: Consultancy, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties.

See more of: Coagulation Alterations in Hematologic Malignancies
See more of: Scientific Workshop on the Interplay between Coagulation and Malignancy
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation